The LX-9 Sequential Intermittent Pneumatic Compression System is designed for the prevention and treatment of vascular issues such as lymphoedema, venous leg ulcers and chronic venous insufficiency.
Headquarters:
Australia
Company Type:
SME
Company size:
Employees
Address:
null
LOW
spending power
